by Michael Morgenstern, MD | Sep 18, 2018 | Blog, Health care, medical cannabinoids
On June 25th, 2018, the U.S. Food & Drug Administration (FDA) approved Epidiolex (cannabidiol, CBD) for treatment of seizures associated with Lennox-Gastaut Syndrome and Dravet Syndrome, two forms of epilepsy. Epidiolex is the first plant-based drug derived from...
by Michael Morgenstern, MD | Sep 11, 2018 | Blog, Common Disorder, Health care
Managing the symptoms of Ulcerative Colitis (UC) can help patients live a more comfortable life. Though there are many conventional treatments to try, medical cannabinoids may also improve the quality of life of someone suffering from the condition. In this blog post,...
Recent Comments